Multicenter Selective Lymphadenectomy Trial Group / Eastern Oncology Group / Cox / Rosenberg SA / Eastern Cooperative Oncology Group / Intergroup / Ibrahim J / / /
IndustryTerm
treatment of brain metastases associated with metastatic melanoma / Treatment of 283 consecutive patients with metastatic melanoma / therapy of American Joint Committee on Cancer / therapy of high-risk resected cutaneous melanoma / treatment of patients with metastatic melanoma / treatment of patients with advanced metastatic malignant melanoma / /
MedicalCondition
familial melanoma / intermediate thickness melanomas / localized cutaneous melanoma / Cancer / JE / Multi-institutional melanoma / II melanoma / brain metastases / metastatic melanoma using chemotherapy / human cancer / early stage melanoma / high-risk resected cutaneous melanoma / Abstract Recurrent/Metastatic Disease / melanomas / Familial atypical multiple mole-melanoma syndrome / high-risk melanoma / cell cancer / melanoma / advanced metastatic malignant melanoma JCO / cutaneous melanoma / I primary cutaneous malignant melanoma / early-stage melanoma / high-risk malignant melanoma / MS / primary human malignant melanomas / Melanoma Epidemiology/Biology / metastatic melanoma / /
MedicalTreatment
chemotherapy / radiation / adjuvant therapy / /
Movie
High and low / /
Organization
American Joint Committee on Cancer Stage I-III / American Joint Committee on Cancer Staging System for Cutaneous Melanoma / /
ASCO Classic Oncology References Melanoma Epidemiology/Biology 1. Barnhill RL, Katzen J, Spatz A, et al The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma. J Cutan Pathol; 2005 Apr; 32